Bio-Techne Q2 FY2022: GAAP EPS $1.94, adj EPS $1.88; rev $269.3M; $0.32 dividend, $400M buyback

BIO-TECHNE Corp

2022-Q2 EPS reported $3.64 revenue$526,995,000

Organic revenue +17% to $269.3M; Protein Sciences organic growth 19% with ProteinSimple up 27% and GMP Proteins >180%.
GAAP EPS $1.94 vs $1.15 YoY; record adjusted EPS $1.88 vs $1.62 YoY.
Adjusted operating income $102.8M, margin 38.3%; up 18% YoY.
Board declared $0.32 quarterly dividend, payable Feb 25, 2022 to holders of record Feb 11, 2022.
New $400M share repurchase program approved, replacing prior program, effective Feb 2, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.